BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2282316)

  • 1. Medullary carcinoma of the thyroid treated by low-dose adriamycin.
    Porter AT; Ostrowski MJ
    Br J Clin Pract; 1990 Nov; 44(11):517-8. PubMed ID: 2282316
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of medullary thyroid carcinomas and carcinoid tumors to adriamycin.
    Ravry MJ
    Cancer Treat Rep; 1977; 61(1):106-7. PubMed ID: 861958
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy for medullary cancer of the thyroid. Phase II trials with adriamycin and cis-platinum administered as monochemotherapy].
    Droz JP; Rougier P; Goddefroy V; Schlumberger M; Gardet P; Parmentier C
    Bull Cancer; 1984; 71(3):195-9. PubMed ID: 6541515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients.
    Gottlieb JA; Hill CS
    N Engl J Med; 1974 Jan; 290(4):193-7. PubMed ID: 4808917
    [No Abstract]   [Full Text] [Related]  

  • 5. Serial serum calcitonin concentrations to evaluate response to therapy of patients with medullary thyroid carcinoma.
    Athanassiades P; Piperingos G; Pandos P; Koutras D; Moulopoulos S
    Chemioterapia; 1988 Jun; 7(3):195-7. PubMed ID: 3168076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of medullary carcinoma of the thyroid to respond to doxorubicin therapy.
    Husain M; Alsever RN; Lock JP; George WF; Katz FH
    Horm Res; 1978; 9(1):22-5. PubMed ID: 618781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for anaplastic carcinoma of the thyroid.
    Sokal M; Harmer CL
    Clin Oncol; 1978 Mar; 4(1):3-10. PubMed ID: 76520
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma.
    Asakawa H; Kobayashi T; Komoike Y; Maruyama H; Nakano Y; Tamaki Y; Matsuzawa Y; Monden M
    Anticancer Res; 1997; 17(4A):2757-62. PubMed ID: 9252711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Failure of chemotherapoy in thyroid cancers (author's transl)].
    Droz JP; Charbord P; Rougier P; Parmentier C
    Bull Cancer; 1981; 68(4):350-2. PubMed ID: 7198496
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).
    Nocera M; Baudin E; Pellegriti G; Cailleux AF; Mechelany-Corone C; Schlumberger M
    Br J Cancer; 2000 Sep; 83(6):715-8. PubMed ID: 10952773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of thyroid carcinoma (author's transl)].
    Brunner K
    Schweiz Rundsch Med Prax; 1982 Apr; 71(14):603-5. PubMed ID: 7201137
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy of stage IV B anaplastic thyroid carcinoma: single institution experience.
    Vrbic S; Pejcic I; Vrbic M; Filipovic S
    J BUON; 2009; 14(1):41-4. PubMed ID: 19373945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of thyroid carcinoma.
    Ahuja S; Ernst H
    J Endocrinol Invest; 1987 Jun; 10(3):303-10. PubMed ID: 3624802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Letter: Undifferentiated cancer of the thyroid. Cure using adriamycin and surgery].
    Chimenes H; Garnier H; Lévy R; Perz R; Chomette G
    Nouv Presse Med; 1975 Jan; 4(1):34. PubMed ID: 1144023
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medullary carcinoma of the thyroid].
    Olesen LL
    Ugeskr Laeger; 1984 Oct; 146(43):3260-4. PubMed ID: 6506297
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of octreotide in the treatment of medullary thyroid carcinoma.
    Frank-Raue K; Ziegler R; Raue F
    Horm Metab Res Suppl; 1993; 27():44-7. PubMed ID: 8330871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination Adriamycin and radiation therapy. A new approach.
    Kim JH; Leeper RD
    Cancer; 1983 Sep; 52(6):954-7. PubMed ID: 6883279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive chemotherapy for anaplastic thyroid carcinoma: combination of cisplatin, doxorubicin, etoposide and peplomycin with granulocyte granulocyte colony-stimulating factor support. Chemotherapy Committee, The Japanese Society of Thyroid Surgery.
    Jpn J Clin Oncol; 1995 Oct; 25(5):203-7. PubMed ID: 7474408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy on anaplastic thyroid carcinoma of valproic acid alone or in combination with doxorubicin, a synthetic chenodeoxycholic acid derivative, or lactacystin.
    Kim TH; Yoo YH; Kang DY; Suh H; Park MK; Park KJ; Kim SH
    Int J Oncol; 2009 May; 34(5):1353-62. PubMed ID: 19360347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological changes of human thyroid medullary carcinoma cell line treated with calcium channel antagonist nifedipine.
    Nakamura A; Kakudo K; Watanabe K; Satoh R; Shimaoka K
    Kitasato Arch Exp Med; 1988 Dec; 61(4):195-200. PubMed ID: 3253470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.